Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Treatment
Quality of life not adversely affected by letrozole after tamoxifen therapy
December 1st, 2005
A survey indicates that quality of life was not adversely affected by the use of letrozole after 5 years of tamoxifen therapy. Researchers in Canada recently conducted a study "to evaluate the impact of letrozole compared with placebo after adjuvant tamoxifen on quality of life (QOL) in the MA.17 trial." "Patients completed the Short Form 36-item Health Survey (SF-36) and the Menopause Specific Quality of Life Questionnaire (MENQOL) at baseline, 6 months, and annually," explained the investigators. "Mean change scores from baseline were compared between groups for summary measures and domains. A response analysis compared the proportion of patients...
Source: Women's Health Weekly (2005-12-01)
|
